Panluminate, Inc.
PrivateLast Round
Grant
Aug 1, 2026
Total Funding Raised
$1.22M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Panluminate, Inc. operates in Healthcare & Life Sciences and is based in New Haven, Connecticut. Its latest recorded funding round was a Grant round in September 2024.
Panluminate, Inc. is a neurotech company that develops infrastructure for whole-brain connectomics, including tissue-staining chemistry, light-sheet microscopy, and AI-powered analysis tools for neuroscience and drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Imaging, Biotech Equipment, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Panluminate, Inc. Comparables
Compare Panluminate, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LifeCanvas Technologies | 85% | |
| Alpenglow Biosciences | 81% | |
| Magnify Biosciences | 81% |
For institutional investors. Book with your work email.
Panluminate, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 1, 2026 | ||||
| Grant | Aug 1, 2026 | ||||
| Grant | Sep 10, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Panluminate, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Center for Complementary and Integrative Health | Grant |
| National Institute on Alcohol Abuse and Alcoholism | Grant |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| National Institute of Mental Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 771% MoM.
- Aug 1, 2026
$455K grant from the National Institute of Mental Health.
For institutional investors. Book with your work email.
Panluminate, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Panluminate, Inc.'s valuation, stock price, and market status.
Is Panluminate, Inc. a public or private company?
Panluminate, Inc. is a private company.
What is the current stock price of Panluminate, Inc.?
Panluminate, Inc. is a private company, so its shares have no public market price. Caplight tracks Panluminate, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Panluminate, Inc. worth (valuation)?
Valuation information for Panluminate, Inc. is not publicly available.
Can I buy Panluminate, Inc. stock?
Panluminate, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Panluminate, Inc.'s last funding round?
Panluminate, Inc.'s most recent funding round was Grant on August 1, 2026.
Who are the main investors in Panluminate, Inc.?
Key investors in Panluminate, Inc. include National Center for Complementary and Integrative Health, National Institute on Alcohol Abuse and Alcoholism, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Mental Health.
Will Panluminate, Inc. IPO soon?
No public IPO plans have been announced for Panluminate, Inc..
How can I track Panluminate, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Panluminate, Inc.'s shares on secondary markets.